Research reportRemission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF)
-
Add time:08/29/2019 Source:sciencedirect.com
IntroductionResearch on the association between electroconvulsive therapy (ECT) and increased brain derived neurotrophic factor (BDNF) levels has produced conflicting result. There have been few studies which have evaluated BDNF levels in clinical contexts where there was remission following treatment. The objective of this study was to investigate whether remission of depression following ECT is associated with changes in BDNF levels.
We also recommend Trading Suppliers and Manufacturers of ect protein (cas 136111-12-1). Pls Click Website Link as below: cas 136111-12-1 suppliers
Prev:Review articleClinical and biological predictors of response to electroconvulsive therapy (ECT): a review
Next:Combining ECT with pharmacological treatment of depressed inpatients in a naturalistic study is not associated with serum BDNF level increase) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder09/03/2019
- Psychiatrie biologiqueECT : de la neuroplasticité aux mécanismes d’actionECT : from neuronal plasticity to mechanisms underlying antidepressant medication effect09/02/2019
- Further improving the cognitive effect profile of electroconvulsive therapy (ECT): The case for studying carbamylated erythropoietin☆09/01/2019
- Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only08/31/2019
- Combining ECT with pharmacological treatment of depressed inpatients in a naturalistic study is not associated with serum BDNF level increase08/30/2019
- Review articleClinical and biological predictors of response to electroconvulsive therapy (ECT): a review08/28/2019
-
Health and Chemical more >